NasdaqGS:INSMBiotechs
Why Insmed (INSM) Is Up 6.2% After Index Removal And Key Respiratory Leadership Hire – And What's Next
In late June 2026, Insmed Incorporated was removed from the NASDAQ-100 and multiple Russell indices, while also appointing industry veteran Samuele Butera as Senior Vice President, Global Respiratory, to lead its respiratory therapeutic area.
This combination of index removals and a high-profile commercial hire highlights a pivotal moment for Insmed’s visibility, investor base, and future respiratory portfolio execution.
We’ll now examine how Insmed’s removal from major indices shapes its...